1

This presentation may contain forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation, supply and demand. Esprinet has based these forward-looking statements on its view and assumptions with respect to future events and financial performance. Actual financial performance could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, readers should not put undue reliance on any forward-looking statements. The information contained in this presentation is subject to change without notice and Esprinet does not undertake any duty to update the forward- looking statements, and the estimates and the assumptions associated with them, except to the extent required by applicable laws and regulations.

2

3

4

The ROCE Driven Strategy keeps inspiring the operational and financial management

  • 9M 2021 P&L performance still growing compared to last year, despite a slowdown in the third quarter:

I. Sales up +9% yoy to 3,211 M€

  • Q3 2021 sales of 974 M€ (-13% yoy)
  • Q2 2021 sales of 1,071 M€ (+16% yoy)
  • Q1 2021 sales of 1,166 M€ (+28% yoy)
  • II. EBITDA Adjusted up +39% to 57.9 M€

    Drivers:

    Organic growth: +11.0 M€ (+26% yoy);

    M&A: 5.3 M€

  • ESPRINET recorded growth almost in line with the market (9%) in the three geographic areas in which it operates
    Italy +7%, Spain +7%, Portugal +80%
  • Gross profit: with a growth of 29% it stood at 5.16%, (compared to 4.35% of 9M 20) with growths in almost all product lines also thanks to the efforts in customer satisfaction improvement
  • Cash Cycle at 13 days, +5 days compared to Q3 20 (+4 days compared to Q2 21)
  • Net Financial Position as of September 30, 2021 negative for

200.8 M€

    • down compared to June 30, 2021 (negative for 104.9 M€) essentially due to changes in the cash conversion cycle;
    • down compared to September 30, 2020 (negative for 14.5
      M€): main drivers being treasury shares buy-back, extra- ordinary dividend payment, the disbursements for the acquisitions made (GTI Group, Dacom S.p.A. and idMAINT Group) and the non-repeatable favorable mismatch between DPO and DSO following the Covid-19 pandemic
  • ROCE at 17.6% mainly due to increased operating profitability

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Esprinet S.p.A. published this content on 11 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 November 2021 02:16:03 UTC.